Turning Point Brands Announces First Quarter 2023 Results Net Sales for Q1 2023 Increased 0.1 Percent Year-Over-Year LOUISVILLE, Ky.–(BUSINESS WIRE)-May 03, 2023-Turning Point Brands, Inc.
ScottsMiracle-Gro Reports Fiscal 2023 Second Quarter Results U.S. Consumer First Half Sales of $1.73B in Line with Record Prior Two Years Fiscal 2Q23 GAAP EPS
Related Articles When Denverite Arend Richard looks at the local and national landscape for cannabis lounges, he sees a homogenous smattering of spaces designed for
Roughly a month after announcing plans to merge several units under Sumitomo Pharma America this July, the drugmaker is making cuts in Massachusetts. Sumitomo Pharma
Roughly a month after announcing plans to merge several units under Sumitomo Pharma America this July, the drugmaker is making cuts in Massachusetts. Sumitomo Pharma
Avadel Pharmaceuticals notched an FDA approval for narcolepsy drug Lumryz on Monday following a multi-year court battle with Jazz Pharmaceuticals. Jazz was forced to delist
Roughly a month after announcing plans to merge several units under Sumitomo Pharma America this July, the drugmaker is making cuts in Massachusetts. Sumitomo Pharma
Avadel Pharmaceuticals notched an FDA approval for narcolepsy drug Lumryz on Monday following a multi-year court battle with Jazz Pharmaceuticals. Jazz was forced to delist
Coming off some recent setbacks, Immatics is rolling out its latest update on a new approach to solid tumors that’s bolstered hopes and inspired a
Roughly a month after announcing plans to merge several units under Sumitomo Pharma America this July, the drugmaker is making cuts in Massachusetts. Sumitomo Pharma